{
    "clinical_study": {
        "@rank": "70343", 
        "arm_group": {
            "arm_group_label": "A.", 
            "arm_group_type": "Experimental", 
            "description": "Testosterone Gel delivered using an applicator"
        }, 
        "brief_summary": {
            "textblock": "This is a multicenter extension trial in adult hypogonadal males. The purpose of this study\n      is to evaluate the safety of testosterone gel delivered using an applicator over an extended\n      period of time."
        }, 
        "brief_title": "A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Male Hypogonadism", 
        "condition_browse": {
            "mesh_term": [
                "Hypogonadism", 
                "Eunuchism"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Completion of the Phase 3 protocol (NCT01665599)\n\n        Exclusion Criteria:\n\n          -  Use of another investigational product\n\n          -  Use of any medications that could be considered anabolic or interfere with androgen\n             metabolism\n\n          -  Use of estrogens, gonadotropin releasing hormone agonists/antagonists, antiandrogens,\n             or human growth hormone\n\n          -  Use of another testosterone product\n\n          -  Chronic use of any drug of abuse"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "145", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01703741", 
            "org_study_id": "000077"
        }, 
        "intervention": {
            "arm_group_label": "A.", 
            "description": "Testosterone Gel delivered using an applicator", 
            "intervention_name": "Testosterone Gel", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Testosterone", 
                "Testosterone enanthate", 
                "Testosterone undecanoate", 
                "Testosterone 17 beta-cypionate", 
                "Methyltestosterone"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "October 31, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Huntsville", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "Medical Affiliated Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newport Beach", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "California Professional Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "San Diego Sexual Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middlebury", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }, 
                    "name": "Connecticut Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aventura", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "South Florida Medical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Clair Shores", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Michigan Institute of Urology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lawrenceville", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Premier Urology Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "University Urology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poughkeepsie", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Premier Medical Group of the Hudson Valley"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "PMG Research of Wilmington"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "Tristate Urologic Services"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warwick", 
                        "country": "United States", 
                        "state": "Rhode Island"
                    }, 
                    "name": "Omega Medical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mount Pleasant", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "Coastal Carolina Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Myrtle Beach", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "Carolina Urologic Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "Clinical Research Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Urology Clinics of North Texas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "Canada", 
                        "state": "Ontario"
                    }, 
                    "name": "St. Joseph's Healthcare"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Bay", 
                        "country": "Canada", 
                        "state": "Ontario"
                    }, 
                    "name": "Private Practice and Clinical Research"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multicenter Extension Trial to Evaluate the Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males", 
        "overall_official": {
            "affiliation": "Ferring Pharmaceuticals", 
            "last_name": "Clinical Development Support", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Canada: Health Canada"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Measurement of total testosterone level occur after subjects have been on a stabilized dose of Testosterone Gel for at least one month in the period between Month 3 and Month 6.", 
            "measure": "Percentage of subjects with a serum total testosterone level of 1500-1799, 1800-2499, or above 2500 ng/dL", 
            "safety_issue": "Yes", 
            "time_frame": "Between Month 3 and Month 6"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01703741"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measurement of total testosterone level occur after subjects have been on a stabilized dose of Testosterone Gel for at least one month in the period between Month 3 and Month 6.", 
                "measure": "Percentage of subjects with a serum total testosterone level greater than 300 ng/dL", 
                "safety_issue": "No", 
                "time_frame": "Between Month 3 and Month 6"
            }, 
            {
                "measure": "Domain scores for the IIEF questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Month 6"
            }, 
            {
                "measure": "Percentage of subjects with a negative ADAM questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Month 6"
            }, 
            {
                "measure": "Domain scores for the MAF questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Month 6"
            }, 
            {
                "measure": "Domain scores for the SF-12 questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Month 6"
            }, 
            {
                "measure": "Percentage of subjects with a serum total testosterone level of 1500-1799, 1800-2499, or above 2500 ng/dL", 
                "safety_issue": "Yes", 
                "time_frame": "Month 3"
            }, 
            {
                "measure": "Percentage of subjects with a serum total testosterone level of 1500-1799, 1800-2499, or above 2500 ng/dL", 
                "safety_issue": "Yes", 
                "time_frame": "Month 6"
            }, 
            {
                "description": "Measurement of total testosterone level occur after subjects have been on a stabilized dose of Testosterone Gel for at least one month in the period between Month 3 and Month 6.", 
                "measure": "Pharmacokinetics of total testosterone measuring AUC\u03c4, Tmax, Cmax, Cave, Cmin, and T1/2", 
                "safety_issue": "No", 
                "time_frame": "Between Month 3 and Month 6"
            }, 
            {
                "description": "Measurement of total testosterone level occur after subjects have been on a stabilized dose of Testosterone Gel for at least one month in the period between Month 3 and Month 6.", 
                "measure": "Pharmacokinetics of DHT (dihydrotestosterone) measuring AUC\u03c4, Tmax, Cmax, Cave, Cmin, and T1/2", 
                "safety_issue": "No", 
                "time_frame": "Between Month 3 and Month 6"
            }
        ], 
        "source": "Ferring Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ferring Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}